Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington’s and Parkinson’s Disease-Reference-Cited by-同舟云学术

Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington’s and Parkinson’s Disease

Published:2020-10-07 Issue:11 Volume:36 Page:1299-1314
ISSN:1673-7067
Container-title:Neuroscience Bulletin
language:en
Short-container-title:Neurosci. Bull.

Author:

Glaser Talita,Andrejew Roberta,Oliveira-Giacomelli Ágatha,Ribeiro Deidiane Elisa,Bonfim Marques Lucas,Ye Qing,Ren Wen-Jing,Semyanov Alexey^ORCID,Illes Peter^ORCID,Tang Yong^ORCID,Ulrich Henning^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Physiology,General Neuroscience

Link

https://link.springer.com/content/pdf/10.1007/s12264-020-00582-8.pdf

Reference175 articles.

1. MacDonald Gillian P.Buckler, Alan J.Altherr, MichaelTagle, DaniloSnell, Russell et al. MEB. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell 1993, 72:971–983.

2. Rikani AA, Choudhry Z, Choudhry AM, Rizvi N, Ikram H, Mobassarah NJ, et al. The mechanism of degeneration of striatal neuronal subtypes in Huntington disease. Ann Neurosci 2014, 21:112–114.

3. Yang W, Xie J, Qiang Q, Li L, Lin X, Ren Y, et al. Gedunin degrades aggregates of mutant huntingtin protein and intranuclear inclusions via the proteasomal pathway in neurons and fibroblasts from patients with Huntington’s disease. Neurosci Bull 2019, 35:1024–1034.

4. Lees AJ, Hardy J, Revesz T, Lila R. Parkinson ’ s disease. Lancet 2009, 373:2055–2066.

5. Jellinger KA. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 2009, 24:114–125.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arctiin Mitigates Neuronal Injury by Modulating the P2X7R/NLPR3 Inflammasome Signaling Pathway;Inflammation;2024-08-17

2. Adenosine and adenosine receptors in metabolic imbalance-related neurological issues;Biomedicine & Pharmacotherapy;2024-08

3. Partners in health and disease: pineal gland and purinergic signalling;Purinergic Signalling;2024-07-20

4. Implications of COVID-19 in Parkinson’s disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration;Purinergic Signalling;2024-03-09

5. P2X7 receptors: a bibliometric review from 2002 to 2023;Purinergic Signalling;2024-02-29